These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23428010)

  • 1. Pharmacological interactions: the next frontier?
    Bonello L; Paganelli F; Laine M
    JACC Cardiovasc Interv; 2013 Feb; 6(2):180-1. PubMed ID: 23428010
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
    Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
    JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive medical therapy alone is not adequate in certain patients with severe symptomatic carotid stenosis.
    Brown MM
    Stroke; 2013 Oct; 44(10):2955-6. PubMed ID: 24046010
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of therapy with Ticagrelor, Prasugrel or high Clopidogrel dose in PCI patients with high on treatment platelet reactivity and genotype variation. TRIPLETE RESET trial.
    Sardella G; Calcagno S; Mancone M; Lucisano L; Pennacchi M; Stio RE; Placentino F; Di Roma A; Cavallo E; Palmirotta R; Guadagni F; Fedele F
    Int J Cardiol; 2015 Sep; 194():60-2. PubMed ID: 26011265
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter by Alexopoulos et al regarding article, "pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel dose versus prasugrel: the RESET GENE Trial".
    Alexopoulos D; Xanthopoulou I
    Circ Cardiovasc Interv; 2013 Feb; 6(1):e11. PubMed ID: 23424274
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention.
    Smith SM; Judge HM; Peters G; Storey RF
    Platelets; 2004 Dec; 15(8):465-74. PubMed ID: 15763887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting.
    Gorchakova O; von Beckerath N; Gawaz M; Mocz A; Joost A; Schömig A; Kastrati A
    Eur Heart J; 2004 Nov; 25(21):1898-902. PubMed ID: 15522468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic comparison of pitavastatin versus atorvastatin on platelet reactivity in patients with coronary artery disease treated with dual antiplatelet therapy.
    Pelliccia F; Rosano G; Marazzi G; Vitale C; Spoletini I; Franzoni F; Speziale G; Polacco M; Greco C; Gaudio C
    Circ J; 2014; 78(3):679-84. PubMed ID: 24389597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis.
    Lotfi A; Schweiger MJ; Giugliano GR; Murphy SA; Cannon CP;
    Am Heart J; 2008 May; 155(5):954-8. PubMed ID: 18440347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin pleiotropy in acute myocardial infarction--is it about timing?
    Puri R; Tuzcu EM
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):766-7. PubMed ID: 23097287
    [No Abstract]   [Full Text] [Related]  

  • 11. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case of the month. Idiopathic dilated cardiomyopathy.
    Parker T
    JAAPA; 2009 Jul; 22(7):70. PubMed ID: 19697577
    [No Abstract]   [Full Text] [Related]  

  • 13. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
    Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-atherosclerotic effect of atorvastatin and clopidogrel alone and in combination in rats.
    Srinivas M; Annapurna A; Reddy YN
    Indian J Exp Biol; 2008 Oct; 46(10):698-703. PubMed ID: 19024167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from prasugrel to clopidogrel: navigating in unknown waters.
    Angiolillo DJ; Rollini F
    JACC Cardiovasc Interv; 2013 Feb; 6(2):166-8. PubMed ID: 23428008
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
    Patti G; Pasceri V; Nusca A; Di Sciascio G
    Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of high atorvastatin dose reloading prior to percutaneous coronary intervention.
    Katsiki N; Athyros VG; Karagiannis A
    Curr Med Res Opin; 2014 Jan; 30(1):55. PubMed ID: 24024869
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial.
    Reed GW; Cannon CP; Waalen J; Teirstein PS; Tanguay JF; Berger PB; Angiolillo DJ; Price MJ
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):190-198. PubMed ID: 26909669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel Dose versus prasugrel: the RESET GENE trial.
    Sardella G; Calcagno S; Mancone M; Palmirotta R; Lucisano L; Canali E; Stio RE; Pennacchi M; Di Roma A; Benedetti G; Guadagni F; Biondi-Zoccai G; Fedele F
    Circ Cardiovasc Interv; 2012 Oct; 5(5):698-704. PubMed ID: 23048056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Managing myocardial infarct in general practice].
    Bonassin F; Wyss C; Schneemann M
    Praxis (Bern 1994); 2010 Jul; 99(14):817-28. PubMed ID: 20607664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.